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A B S T R A C T
Objective: Risk stratification within the ICD population warrants the examining of the role of protective- and risk
factors. Current study examines the association between Type D personality, pessimism, and optimism and risk
of ventricular tachyarrhythmias (VTa's) and mortality in patients with a first-time ICD 6 years post implantation.
Methods: A total of 221 first-implant ICD patients completed questionnaires on optimism and pessimism (Life
Orientation Test) and Type D personality (Type D scale DS14) 10 to 14 days after implantation. VTa's and all-
cause mortality 6 years post implant comprised the study endpoints.
Results: Ninety (40.7%) patients had experienced VTa's and 37 (16.7%) patients died, 12 (5.4%) due to a cardiac
cause. Adjusted logistic regression analysis showed that pessimism was significantly associated with increased
risk of VTa's (OR = 1.09; 95% CI = 1.00–1.19; p= .05). Type D personality (OR = 1.05; 95% CI = 0.47–2.32;
p = .91) and optimism (OR = 1.00; 95% CI = 0.90–1.12; p = .98) were not associated with VTa's. None of the
personality types were associated with mortality.
Conclusion: Pessimism was associated with VTa's but not with mortality. No significant association with either of
the endpoints was observed for Type D personality and optimism. Future research should focus on the coexistent
psychosocial factors that possibly lead to adverse cardiac prognosis in this patient population.
1. Introduction
Implantable cardioverter defibrillator (ICD) therapy is the first-line
treatment, both as primary (patients who are at risk to experience
ventricular tachyarrhythmias (VTa's)) and secondary prevention (pa-
tients who have experienced VTa's), for patients at risk of sudden car-
diac death (SCD) due to life-threatening VTa's [1]. ICD therapy is as-
sociated with better survival as compared to anti-arrhythmic drugs [2],
although this remains precarious for particular patient subgroups (e.g.
the elderly, primary prevention) [3–5]. Hence, risk stratification with
respect to which patients will benefit from implantation with an ICD
still remains a challenge in clinical practice, warranting that we con-
tinue to strive to identify risk factors related to VTa's and mortality to
further refine prognostic stratification.
Besides clinical risk factors (e.g. left ventricular ejection fraction
(LVEF) [1] and shocks [6,7]), a range of emotional factors, such as
anxiety [8,9], depression [10], anger [11], ICD concerns [12], post-
traumatic stress disorder (PTSD) [13], and impaired quality of life [14]
have been shown to contribute to adverse health outcomes, including
survival and VTa's in the ICD population. The association between these
psychological vulnerability factors and health outcomes are in-
dependent of biomedical risk factors and severity of the underlying
https://doi.org/10.1016/j.genhosppsych.2019.11.009
Received 31 July 2019; Received in revised form 25 November 2019; Accepted 25 November 2019
⁎ Corresponding author at: Tilburg University, PO Box 90153, 5000 LE Tilburg, the Netherlands.
E-mail address: m.habibovic@uvt.nl (M. Habibović).
General Hospital Psychiatry 62 (2020) 56–62
0163-8343/ © 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
T
disease [15,16]. Distress is particularly manifest in patients with a Type
D personality, who have the tendency to experience negative emotions
(e.g. worrying) and not to share these with others [17]. Some studies
have found that Type D personality is associated with increased risk of
mortality and VTa's [12,18] in the ICD population, while other studies
found no association [15,19]. Furthermore, it is unclear whether the
association persists over a prolonged period of time. It is observed that
anxious and depressed ICD patients tend to have a more overall pessi-
mistic view of the world that may result in adverse health outcomes
[20,21]. On the other hand, evidence suggests that dispositional opti-
mism (e.g. the overall tendency to have positive expectations about
future outcomes) is protective [21] and also associated with better
health behaviours [22,23], better health outcomes [24], and reduced
mortality risk [24] in the general cardiac population. As we do not
know whether this is generalizable to the ICD population, it is im-
portant to examine whether specific personality traits make patients
vulnerable or resilient for VTa's and mortality on the long-term. This
might provide opportunities to optimize healthcare based on patients'
preferences and needs, which in turn might lead to better clinical
outcomes for specific ICD patient subgroups.
Hence, the objective of the current study was to examine the asso-
ciation between Type D personality, pessimism, and optimism and risk
of mortality and VTa's in patients with a first-time ICD 6 years post
implantation.
2. Methods
2.1. Patient population and procedure
Consecutive patients implanted with a first-time ICD between April
2010 and February 2013 enrolled in the WEB-based distress manage-
ment program for implantable CARdioverter dEfibrillator patients
(WEBCARE), a multicenter randomized controlled trial, comprised the
study cohort [25]. Patients were recruited from six Dutch referral
hospitals (Amphia Hospital, Breda; Canisius-Wilhelmina Hospital, Nij-
megen; Catharina Hospital, Eindhoven; Erasmus Medical Centre, Rot-
terdam; Onze Lieve Vrouwe Gasthuis, Amsterdam; Vlietland Hospital,
Schiedam).
Patients between 18 and 75 years of age, who underwent a first-time
ICD implantation were approached for participation by an ICD nurse or
technician. Patients with significant cognitive impairments (e.g. de-
mentia), history of psychiatric illness other than depressive or anxiety
disorders, life expectancy< 1 year, on the waiting list for heart trans-
plantation, life-threatening comorbidities (e.g. malignancies), lack of
internet/computer skills, or insufficient knowledge of the Dutch lan-
guage were excluded. Participants were requested to complete a set of
validated and standardized questionnaires in the first year post implant
(i.e., at baseline, 3-, 6-, and 12 months). More details on the study
procedure has been described elsewhere [26]. The study was conducted
according to the ethical guidelines of the Helsinki Declaration, and the
protocol has been approved by the Medical Ethical Committees of all
participating centres (METC number MEC-2009-211/NL25617.078.09;
NCT00895700). All participants were informed orally and in writing
about the study and all provided written informed consent.
2.2. Measurements
2.2.1. Sociodemographic and clinical variables
Purpose-designed questionnaires were used at baseline to collect
information on patients' age and gender (i.e. 0 ‘male’ and 1 ‘female’).
Information on clinical variables was obtained from patients' medical
records and included systolic dysfunction (LVEF), ICD indication (pri-
mary versus secondary), aetiology of CAD (i.e. 0 ‘no’ and 1 ‘yes’), ICD
shocks (i.e. 0 ‘no’ and 1 ‘yes’ and ‘appropriate and inappropriate’).
Comorbidities were assessed with the Charlson Comorbidity Index
(CCI).
2.2.2. Type D personality
Type D personality was assessed with the Type D scale (DS14) [27].
This self-report questionnaire consists of two distinct subscales com-
prised of 7 items each, i.e. Social Inhibition (SI) (e.g. “I am a ‘closed’ kind
of person”) and Negative Affectivity (NA) (e.g. ‘I am often irritated’).
Items are answered on a 5-point Likert scale ranging from 0 (false) to 4
(true), with total scores on the scales ranging from 0 to 28. Type D is
defined by a standardized cut-off score of ≥10 on both subscales. The
questionnaire is internally consistent, with Cronbach's alpha's of 0.86
for SI and 0.88 for NA, respectively [27]. Previous research has shown
that Type D personality is a stable construct over time [28].
2.2.3. Optimism and pessimism
The Life Orientation Test (LOT) was used to assess the personality
traits optimism and pessimism [29]. The total questionnaire consists of
12 items that are answered on a 5-point Likert scale, ranging from 0
(very much disagree) to 4 (very much agree). The construct of optimism
is comprised of 4 items (e.g. ‘In uncertain times, I usually expect the best’)
while 4 items contribute to the construct of pessimism (e.g. ‘I hardly ever
expect thing to go my way’). The remaining 4 items do not contribute to
the sum score, as they represent ‘filler items’. Both subscales have a
total score range from 0 to 16, with a higher score reflecting a higher
level of the respective traits.
2.3. Study endpoints
The study endpoints were all-cause mortality and VTa's 6 years post
ICD implant. The follow-up time ranged from 4 to 7 years, with a mean
of 5.82 ± 0.81 years (IQR = 1). Not all centres were able to provide
information on cause of death. Therefore, cardiac-related mortality
could not been included as an endpoint separately. Information on
mortality and VTa's were obtained from the patients' medical records.
Based on stored electrograms and ICD data, electrophysiologists and/or
the treating cardiologists judged the appropriateness of ICD therapies.
Cause of death and date were derived from patients' medical record by
the cardiologists associated with the recruitment centre.
2.4. Statistical analysis
Baseline characteristics were assessed using mean scores with
standard deviations (SD) (continuous variables) and frequencies (cate-
gorical variables) for descriptive purposes. These are presented as
means± SD and percentages for the total sample. In order to handle
missing data, pairwise deletion was performed. Chi-square tests and t-
tests were performed in order to examine potential systematic differ-
ences between patients who were included in the analysis and patients
who were excluded. Univariable and multivariable hierarchical binary
logistic regression analyses were performed to examine the associations
between different personality traits (i.e., optimism, pessimism, Type D)
and VTa's. Cox-Regression analysis was performed to examine the as-
sociation between personality traits and all-cause mortality. A priori
based on the literature, we had decided to adjust all multivariable
models for demographic (gender, age) and clinical (LVEF, ICD indica-
tion, CAD aetiology, shocks, CCI) covariates. New York Heart
Association (NYHA) functional class was not included into the models
because of missing data (N = 186). Instead, we added LVEF as in-
dication of heart disease severity [30]. Shocks were excluded as a
covariate in the analysis on ventricular arrhythmias. In the first model,
the different personality traits were entered separately (optimism,
pessimism, or Type D) for all-cause mortality and VTa's, respectively. In
model 2, model 1 was adjusted for the aforementioned demographic
covariates. Finally, the medical covariates were added in model 3. As-
sumptions for all multivariable analyses were checked and met. A p-
value of< .05 was considered statistically significant. IBM SPSS Sta-
tistics version 24 was used to perform all analyses.
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3. Results
3.1. Patient characteristics
Of 1024 patients approached for participation, 562 were eligible for
study inclusion. Of the 562 patients, 340 patients signed informed
consent. Because of missing data on dependent and independent vari-
ables, 35% (n = 119) of patients were excluded from analysis, leaving
221 patients in the analysis with respect to VTa's. From 3 additional
patients it was not possible to establish the data of death. Hence, these
patients were excluded from the all-cause mortality analysis, resulting
in N = 218 for those models. Patients excluded from analysis were less
likely to use ACE inhibitors (p < .01), statins (p < .01), and more
likely to use psychotropic medication (p = .02). No other systematic
differences between included and excluded patients on baseline char-
acteristics were found. Baseline characteristics of the current sample are
presented in Table 1. The majority of patients were male (184/221,
83.3%), with a mean age of 58.95 ± 9.88 years at the time of im-
plantation. During the follow-up period, 59 (26.7%) patients received a
shock (either appropriate and/or inappropriate), 90 (40.7%) had ex-
perienced VTa's, 37 (16.7%) patients died of which 12 (5.4%) patients
died due to a cardiac cause. No information on the other causes of death
was available.
3.2. Type D personality, ventricular arrhythmias and all-cause mortality
Type D personality was not significantly associated with VTa's
(OR = 1.16; 95% CI = 0.54–2.46; p = .71) in univariable analysis.
This association remained non-significant (OR = 1.08; 95%
CI = 0.50–2.33; p = .85) after adding age and gender as covariates in
Model 2 (χ2 (3, N = 221) = 8.10, p = .04). Being female was asso-
ciated with a decreased risk of VTa's (OR = 0.32; 95% CI = 0.14–0.75;
p < .01). In Model 3, clinical covariates were additionally added as
covariates (i.e., ICD indication, LVEF, CCI, CAD aetiology). The
association between Type D personality and VTa's remained non-sig-
nificant (OR = 1.05; 95% CI = 0.47–2.32; p = .91). Of the covariates,
female gender persisted to be associated with a decreased risk
(OR = 0.36; 95% CI = 0.15–0.87; p = .02), while secondary ICD in-
dication was associated with an increased risk of VTa's (OR = 2.40;
95% CI = 1.21–4.78; p = .01). No significant associations were ob-
served between the other covariates that were added to the model and
outcomes (see Table 2).
With respect to all-cause mortality, univariable analysis showed no
significant association with Type D personality (HR = 0.81; 95%
CI = 0.31–2.15; p = .67). This finding did not change after the ad-
justment for demographic (i.e., age and gender – Model 2) and clinical
(ICD indication, CAD aetiology, shocks, CCI, and LVEF - Model 3)
variables. None of the covariates in the model were associated with the
study endpoint (see Table 2).
3.3. Pessimism, ventricular arrhythmias and all-cause mortality
With respect to VTa's, univariable logistic regression analysis
showed no significant association with pessimism (OR = 1.08; 95%
CI = 1.00–1.18; p = .06). When adding demographic covariates (i.e.
age and gender) in Model 2 (χ2 (3, N = 221) = 11.69, p < .01),
pessimism remained a non-significant correlate of VTa's (OR = 1.09;
95% CI = 1.00–1.18; p = .06). Of the covariates, only female gender
was a significant correlate of decreased risk of VTa's (OR = 0.32; 95%
CI = 0.14–0.75; p < .01). In model 3 (χ2 (7, N = 221) = 20.08,
p < .01), pessimism was significantly associated with an increased risk
(OR = 1.09; 95% CI = 1.00–1.19; p = .050), after controlling for
gender, ICD indication, CAD aetiology, CCI, and LVEF (see Table 3).
The association between female gender and VTa's remained significant
(OR = 0.35; 95% CI = 0.14–0.86; p = .02). Secondary ICD indication
was associated with an increased risk of VTa's (OR = 2.43; 95%
CI = 1.21–4.88; p = .01). No other significant associations were found
(see Table 3).
Table 1
Patient baseline characteristics of the total sample.
Total Ventricular tachyarrhythmia's All-cause mortality
N = 221 N = 90 N = 131 N = 34 N = 184
Yes No p Yes No p
Demographic
Sex (female) 37(16.7) 8(21.6) 29 (78.4) 0.02 6(16.2) 31(83.8) 1.00
Age 58.9 ± 9.9 58.6 ± 9.7 59.2 ± 10.0 0.67 64.1 ± 6.5 58.0 ± 10.1 0.001
Clinical
Secondary indication 63(28.5) 36(57.1) 27(42.9) 0.003 8(12.7) 55(87.3) 0.59
Shocks (any) 59(26.7) – – – 10(16.9) 49(83.1) 0.90
Ischemic heart disease 138(62.4) 55 (39.9) 83(60.1) 0.84 24(17.6) 112(82.4) 0.38
CCI 1.69 ± 0.9 1.6 ± 0.8 1.7 ± 1.1 0.55 2.2 ± 1.4 1.6 ± 0.9 0.002
LVEF 31.3 ± 12.2 32.3 ± 12.4 30.8 ± 12.0 0.38 29.8 ± 9.8 31.8 ± 12.6 0.38
Medication
Beta-blockers 183(82.8) 68(37.2) 115(62.8) 0.03 26(14.4) 155(85.6) 0.39
Diuretics 114(51.4) 40(35.1) 74(64.9) 0.11 20(17.9) 92(82.1) 0.45
ACE-inhibitors 146(66.1) 53(36.3) 93(63.7) 0.09 20(13.9) 124(86.1) 0.44
ARB 34(15.4) 16(47.1) 18(52.9) 0.53 5(15.2) 28(84.8) 1.00
Statins 148(67.0) 60(40.5) 88(59.5) 1.00 23(15.8) 123(84.2) 1.00
Amiodarone 19(8.6) 11(57.9) 8(42.1) 0.18 5(26.3) 14(73.7) 0.31
Digoxine 10(4.5) 1(10.0) 9(90.0) 0.09 2(20.0) 8(80.0) 1.00
Psychotropic medication 15(6.8) 10(66.7) 5(33.3) 0.07 3(20.0) 12(80.0) 0.91
Psychological
Optimism 11.3 ± 2.6 11.3 ± 2.7 11.3 ± 2.6 0.91 11.2 ± 2.9 11.3 ± 2.6 0.78
Pessimism 5.6 ± 3.3 6.1 ± 3.6 5.3 ± 3.0 0.06 5.9 ± 3.5 5.5 ± 3.2 0.51
Type D personality 32(14.5) 14(43.8) 18(56.3) 0.86 5(16.1) 26(83.9) 1.00
ACE-inhibitors = angiotensin converting enzyme inhibitors; ARB = angiotensin receptor blocker; CCI = Charlson comorbidity index; LVEF = left ventricular
ejection fraction.
For continuous variables mean ± SD is reported; for categorical variables N(%) is reported.
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In unadjusted analysis, pessimism was not significantly associated
with all-cause mortality (HR = 1.01; 95% CI = 0.91–1.12; p = .91).
After the addition of age and gender in Model 2, the association with
pessimism was unchanged. The association between pessimism and
mortality remained non-significant in Model 3 after adjustment for ICD
indication, LVEF, shocks, history of ischemic heart disease, CCI, age,
and gender. None of the covariates were associated with mortality (see
Table 3).
3.4. Optimism, ventricular arrhythmias and all-cause mortality
In the unadjusted binary logistic regression analysis, no significant
association was found between optimism and VTa's (OR = 0.99; 95%
CI = 0.90–1.10; p = .91) (see Table 4). After adjustment for age and
gender in model 2 (χ2 (3, N = 221) = 8.09, p = .04), optimism re-
mained non-significant (OR = 1.01; 95% CI = 0.91–1.12; p = .88),
while being female was significantly associated with a decreased risk of
VTa's (OR = 0.32; 95% CI = 0.14–0.75; p < .01). In model 3 (χ2 (7,
N = 221) = 16.16, p = .02), after additional adjustment for ICD in-
dication, CAD aetiology, CCI, and LVEF, the association between opti-
mism and VTa's did not change (OR = 1.00; 95% CI = 0.90–1.12;
p = .98). Again, being female was associated with decreased risk of
VTa's (OR = 0.35; 95% CI = 0.15–0.87; p = .02). Secondary ICD in-
dication was associated with an increased risk (OR = 2.40; 95%
Table 2
Associations between Type D personality and ventricular arrhythmias and all-cause mortality.f
Ventricular arrhythmias All-cause mortality
B S.E. Wald OR 95% CI p HR 95%CI p
Model 1
Type D 0.15 0.39 0.14 1.16 0.54–2.46 0.70 0.81 0.31–2.15 0.67
Model 2
Type D 0.08 0.39 0.04 1.08 0.50–2.33 0.85 0.74 0.25–2.21 0.59
Age −0.01 0.01 0.84 0.99 0.96–1.02 0.34 1.07 0.99–1.15 0.07
Gendera −1.14 0.43 6.82 0.32 0.14–0.75 < 0.01 0.83 0.30–2.30 0.71
Model 3
Type D 0.05 0.41 0.01 1.05 0.47–2.32 0.91 0.95 0.29–3.15 0.94
Age −0.01 0.02 0.40 0.99 0.96–1.02 0.53 1.07 0.99–1.15 0.07
Gender −1.03 0.45 5.17 0.36 0.15–0.87 0.02 0.90 0.31–2.57 0.84
LVEFb −0.003 0.01 0.05 1.00 0.97–1.02 0.83 1.00 0.96–1.04 0.97
Indicationc 0.88 0.35 6.02 2.40 1.21–4.78 0.01 0.75 0.27–2.11 0.59
IHD −0.22 0.32 0.47 0.80 0.43–1.50 0.49 1.54 0.64–3.72 0.34
Shocksd – – – – – – 0.58 0.23–1.48 0.25
CCIe −0.01 0.16 0.003 0.99 0.73–1.35 0.96 0.99 0.73–1.34 0.92
CCI = Charlson comorbidity index; IHD = ischemic heart disease.
a Male.
b Continuous scale.
c Primary indication.
d Appropriate or inappropriate shocks: yes.
e Continuous scale.
f Logistic regression analysis.
Table 3
Associations between pessimism and ventricular arrhythmias and all-cause mortality.f
Ventricular arrhythmias All-cause mortality
B S.E. Wald OR 95% CI p HR 95% CI p
Model 1
Pessimism 0.08 0.04 3.51 1.08 1.00–1.18 0.06 1.01 0.91–1.12 0.91
Model 2
Pessimism 0.08 0.04 3.55 1.09 1.00–1.18 0.06 1.03 0.91–1.16 0.69
Age −0.01 0.02 0.94 0.99 0.96–1.02 0.33 1.06 0.99–1.14 0.12
Gendera −1.15 0.44 6.92 0.32 0.16–0.75 < 0.01 0.64 0.21–1.93 0.43
Model 3
Pessimism 0.09 0.05 3.83 1.09 1.00–1.19 0.050 1.03 0.90–1.17 0.66
Age −0.01 0.02 0.49 0.99 0.96–1.02 0.49 1.07 0.99–1.15 0.09
Gender −1.05 0.46 5.28 0.35 0.14–0.86 0.02 0.82 0.26–2.54 0.72
LVEFb −0.002 0.01 0.02 1.00 0.97–1.03 0.89 0.99 0.96–1.04 0.96
Indicationc 0.89 0.36 6.25 2.43 1.21–4.88 0.01 0.82 0.27–2.43 0.72
IHD −0.24 0.32 0.55 0.79 0.42–1.48 0.46 1.60 0.68–3.73 0.28
Shocksd – – – – – – 0.59 0.23–1.48 0.26
CCIe −0.004 0.16 0.001 1.00 0.73–1.36 0.98 0.98 0.74–1.30 0.90
CCI = Charlson comorbidity index; IHD = ischemic heart disease.
a Male.
b Continuous scale.
c Primary indication.
d Appropriate or inappropriate shocks: yes.
e Continuous scale.
f Logistic regression analysis.
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CI = 1.20–4.78; p = .01). No significant influences of other covariates
were found (see Table 4).
Regarding all-cause mortality, the unadjusted logistic regression
analysis showed no significant association with optimism (HR = 0.92;
95% CI = 0.81–1.05; p = .23). In model 2, adding age and gender as
covariates, the association of optimism with mortality remained un-
changed. After additional adjustment for clinical covariates in Model 3,
the influence of optimism remained non-significant. Other covariates
were not significantly associated with all-cause mortality (see Table 4).
4. Discussion
The aim of the current study was to investigate the association be-
tween personality traits and VTa's and all-cause mortality, respectively,
in a consecutive cohort of patients with a first-time implant ICD during
6 years of follow-up. We did not find a significant association between
Type D personality and VTa's nor between Type D and mortality. The
results for optimism were similar. By contrast, pessimism was asso-
ciated with increased risk of VTa's after statistical adjustment for pos-
sible confounding clinical and demographic variables. No association
between pessimism and all-cause mortality was observed.
The lack of significant association between Type D personality and
VTa's and mortality, respectively, is not in line with previous studies in
ICD patients [12,18]. The incongruent findings across studies on Type D
and health outcomes in the ICD population may be explained by het-
erogeneity in follow-up duration (e.g. short-term), sample size (e.g.
large sample sizes), and different statistical methods used for data
analyses (e.g. survival analysis). As current study involves a long-term
follow-up period of six years, the incongruity with previous findings
might indicate that the predictive value of Type D personality on sur-
vival within the ICD population is hypothetically short-term. Another
reason for the current negative findings could be the use of all-cause
rather than cardiac-related mortality as endpoint [31,32]. The asso-
ciation between Type D personality and mortality is believed to work
through biological, disease-specific mechanistic pathways (e.g. in-
creased pro-inflammatory cytokines) and is therefore expected to be
markedly more related to cardiac mortality and morbidity [33]. It was
not possible for all centers to provide information on cause of death.
Hence, we were not able to look at cardiac-related mortality separately.
Moreover, previous research has shown that the combination of Type D
personality and anxiety or concerns about ICD treatment increases the
risk of mortality [12] or VTa's [34], suggesting a possible cumulative
effect of co-existing emotional and personality factors and that psy-
chosocial risk factors often cluster together to influence health out-
comes [35]. Therefore, future research should focus on the interplay
between psychological states and underlying personality traits in order
to design effective interventions that meet patients' needs in order to
improve patients' outcomes. Moreover, although the general perception
is that personality is stable and difficult to change [36], previous re-
search has shown that certain interventions (e.g. cognitive behavioural
therapy, assertiveness training) are of beneficial value for interpersonal
functioning of Type D patients [37] and may thus provide opportunities
for improvement of negative outcomes within this population.
In the current study, we also found that women had a decreased risk
of VTa's as compared to men. Previous research has shown that elec-
trophysiological parameters prone to the effect of sex hormones (i.e.
oestrogen, testosterone), resulting in a difference in risk for VTa's be-
tween men and women [38]. This suggests a more gender specific ap-
proach of care needed in the ICD population. With respect to current
findings, future studies should look into possibilities to design inter-
ventions which aim to reduce pessimism. Evaluating whether these
interventions are effective and also reduce the risk of adverse outcomes
would provide a stronger evidence base and could be implemented in
the clinical practice.
To the best of our knowledge, this is one of the first studies ex-
amining the association between dispositional pessimism and adverse
outcomes in ICD patients. An increased risk was found for VTa's in re-
lation to pessimism. This finding could be explained by the interrelation
between dispositional pessimism, negative emotions and sympathetic
nervous system activation [39]. According to Lampert [40], VTa's are
linked with negative emotions by their altering effect on the autonomic
nervous system. This alteration may lead to insufficient repolarisation
of the myocardium and VTa's in vulnerable patients [41]. We found no
significant association between optimism and VTa's and mortality,
Table 4
Associations between optimism and ventricular arrhythmias and all-cause mortality.f
Ventricular arrhythmias Cause mortality
B S.E. Wald OR 95% CI p HR 95% CI p
Model 1
Optimism −0.006 0.05 0.01 0.99 0.90–1.10 0.91 0.92 0.81–1.05 0.23
Model 2
Optimism 0.01 0.05 0.03 1.01 0.91–1.12 0.88 0.94 0.83–1.08 0.38
Age −0.01 0.01 0.88 0.99 0.96–1.02 0.35 1.06 0.99–1.14 0.12
Gendera −1.15 0.44 6.90 0.32 0.14–0.75 < 0.01 0.74 0.30–1.84 0.51
Model 3
Optimism 0.002 0.06 0.001 1.00 0.90–1.12 0.98 0.97 0.84–1.13 0.71
Age −0.01 0.02 0.42 0.99 0.96–1.02 0.52 1.07 0.99–1.15 0.08
Gender −1.04 0.46 5.18 0.35 0.15–0.87 0.02 0.86 0.30–2.50 0.79
LVEFb −0.003 0.01 0.05 1.00 0.97–1.02 0.83 1.00 0.96–1.05 0.92
Indicationc 0.88 0.35 6.18 2.40 1.20–4.78 0.01 0.80 0.27–2.35 0.68
IHD −0.22 0.32 0.49 0.80 0.43–1.49 0.48 1.46 0.60–3.59 0.41
Shocksd – – – – – – 0.58 0.23–1.48 0.25
CCIe −0.01 0.16 0.002 0.99 0.73–1.35 0.98 1.01 0.74–1.37 0.98
CCI = Charlson comorbidity index; IHD = ischemic heart disease.
All p values equal to or below .05 are bold
This is the trait of interest in this table hence Italic
a Male.
b Continuous scale.
c Primary indication.
d Appropriate or inappropriate shocks: yes.
e Continuous scale.
f Logistic regression analysis.
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respectively. Previous research in multiple cardiac populations has
found that dispositional optimism may protect against negative health
related outcomes, such as mortality [24] and health related quality of
life [42]. This is at odds with our finding, which may be attributed to
the relatively small sample size of the WEBCARE cohort. Speculatively,
it is also possible that optimism might only be protective on the short-
but not long-term in the ICD population or that the effect of optimism
on health-related outcomes might be mediated by other psychosocial
factors (e.g. treatment expectations [43]) not added in our analyses.
Hence, future research should look into potential mediating mechan-
isms and duration of potential protective effect of positive psycholo-
gical factors and health outcomes.
Optimism and pessimism are not necessarily traits that are at op-
posite ends of the same continuum but may coexist [44], providing
opportunities for intervention. Thus, enhancing positive psychological
states on a low-threshold basis could lead to beneficial health outcomes
in ICD patients [45]. In order to reach their full potential, it is suggested
to combine positive psychology interventions with stress reducing
techniques and physical activity [46]. Toise et al. [47] showed in a yoga
pilot intervention that aimed to reduce distress in ICD patients a de-
creased risk of VTa's, less concerns about the ICD firing, and more self-
compassion in the intervention group compared to the control condi-
tion. Therefore, focusing on patients' personality and needs in clinical
care could be of added value in addition to interventions already of-
fered through existent routine clinical pathways.
The results of the current study should be interpreted with the fol-
lowing limitations in mind. First, because of lack of information on the
‘time-to-event’, we could not perform Cox regression analyses. Second,
medical records frequently did not provide information on the cause of
death of patients, which resulted in ambiguity with respect to cause of
death (i.e., all-cause versus cardiac), which may have influenced the
results. Third, the relatively small sample size has limited the number of
covariates that we could include in the statistical analyses. Hence,
possibly important covariates such as psychiatric illness or medication
use were not included in the models. Finally, patients who were ex-
cluded from the analysis were more likely to use psychotropic medi-
cation, this might have resulted in an underrepresentation of this group
in the current sample. A large scale study covering a more re-
presentative sample is advocated in the future. Despite these limita-
tions, this study is one of only few studies that have looked at the as-
sociation between psychosocial factors in relation to mortality and
VTa's in ICD patients with a long-term follow-up.
In conclusion, the findings of the current study have shown no effect
of Type D personality and dispositional optimism on VTa's and mor-
tality in ICD patients. However, an association between pessimism and
VTa's was distinguished. Further, sufficiently powered studies, applying
more robust statistical methods (e.g. survival analysis) are warranted to
confirm our finding that pessimism is related to VTa's in ICD patients,
with respect to optimizing risk stratification. Future research should
also focus on the coexistent psychosocial factors that possibly lead to
worse adverse cardiac prognosis in this patient population (such as
psychiatric disorders, low socioeconomic status). Insight into these
factors could lead to interventions that meet patients' needs to a bigger
extent and favour the inhibition of disease progression.
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